Predictive Oncology Subsidiary, Helomics, Signs Collaborative Research Agreement with ChemImage to Expand Personalized Medicine to Prostate Cancer Prognosis and Treatment June 26, 2019 - NASDAQ Companies 0 » View More News for June 26, 2019